9708853|t|The beta-oxidation of arachidonic acid and the synthesis of docosahexaenoic acid are selectively and consistently altered in skin fibroblasts from three Zellweger patients versus X-adrenoleukodystrophy, Alzheimer and control subjects.
9708853|a|The beta-oxidation of [3H] arachidonic acid (AA; 20:4 n-6) and the conversion of [1-14C]eicosapentaenoic acid (EPA, 20:5 n-3) to docosahexaenoic acid (DHA, 22:6 n-3) have been studied in skin fibroblasts from patients with inherited peroxisomal diseases, such as Zellweger (ZW) and X-linked adrenoleukodystrophy (X-ALD), from patients with Alzheimer's disease (AD), a non-inherited neuropathology, and from controls. EPA is not converted to DHA, while there is enhanced formation of the intermediate product 22:5 n-3 in ZW, when compared to X-ALD, AD and controls. We also confirmed that AA is not beta-oxidized to 4,7,10-hexadecatrienoic acid (16:3), a metabolite produced by peroxisomes, while being more effectively converted to the elongation product 22:4, in ZW, in comparison to X-ALD, AD and controls. The data demonstrate a defect in DHA synthesis and in AA beta-oxidation, and the occurrence of associated adaptative modifications in the metabolism of these long chain PUFA, in three Italian ZW patients.
9708853	22	38	arachidonic acid	Chemical	MESH:D016718
9708853	60	80	docosahexaenoic acid	Chemical	MESH:D004281
9708853	153	162	Zellweger	Disease	MESH:D015211
9708853	163	171	patients	Species	9606
9708853	179	201	X-adrenoleukodystrophy	Disease	MESH:D000326
9708853	203	212	Alzheimer	Disease	MESH:D000544
9708853	258	260	3H	Chemical	MESH:D014316
9708853	262	278	arachidonic acid	Chemical	MESH:D016718
9708853	316	344	[1-14C]eicosapentaenoic acid	Chemical	-
9708853	346	349	EPA	Chemical	MESH:D015118
9708853	351	358	20:5 n-	Chemical	-
9708853	364	384	docosahexaenoic acid	Chemical	MESH:D004281
9708853	386	389	DHA	Chemical	MESH:D004281
9708853	391	399	22:6 n-3	Chemical	-
9708853	444	452	patients	Species	9606
9708853	458	488	inherited peroxisomal diseases	Disease	MESH:D030342
9708853	498	507	Zellweger	Disease	MESH:D015211
9708853	509	511	ZW	Disease	MESH:D015211
9708853	517	546	X-linked adrenoleukodystrophy	Disease	MESH:D000326
9708853	548	553	X-ALD	Disease	MESH:D000326
9708853	561	569	patients	Species	9606
9708853	575	594	Alzheimer's disease	Disease	MESH:D000544
9708853	596	598	AD	Disease	MESH:D000544
9708853	652	655	EPA	Chemical	MESH:D015118
9708853	676	679	DHA	Chemical	MESH:D004281
9708853	755	757	ZW	Disease	MESH:D015211
9708853	776	781	X-ALD	Disease	MESH:D000326
9708853	783	785	AD	Disease	MESH:D000544
9708853	850	878	4,7,10-hexadecatrienoic acid	Chemical	MESH:C094145
9708853	999	1001	ZW	Disease	MESH:D015211
9708853	1020	1025	X-ALD	Disease	MESH:D000326
9708853	1027	1029	AD	Disease	MESH:D000544
9708853	1077	1080	DHA	Chemical	MESH:D004281
9708853	1213	1217	PUFA	Chemical	MESH:D005231
9708853	1236	1238	ZW	Disease	MESH:D015211
9708853	1239	1247	patients	Species	9606
9708853	Association	MESH:D016718	MESH:D000326
9708853	Comparison	MESH:D004281	MESH:D015118
9708853	Association	MESH:D004281	MESH:D000326
9708853	Association	MESH:D016718	MESH:D000544
9708853	Association	MESH:D004281	MESH:D000544
9708853	Association	MESH:D016718	MESH:D015211
9708853	Association	MESH:D004281	MESH:D015211

